Patients of age < 50 showed higher prevalence of CD8+ T cells in tumor parenchyma (p‐value = 0.04, Figure 2a), and higher ratios of M1 TAMs in both tumor parenchyma and stroma (p‐value = 0.05 and 0.04, respectively, Figure 2b). This evidence concerns the gene CD8A and neoplasm.